Fact CheckerSign in

NCT04906707Completed

Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease

Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease (HIPAS)

Source: ClinicalTrials.gov · Last updated 20 Apr 2025

Brief summary (registry, in English)

This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
44 (actual)
First submitted
27 May 2021
Start date
27 Oct 2021
Primary completion date
5 Mar 2024
Lead sponsor
Emory University
NCT number
NCT04906707

What you commit to

  • Study type: Interventional
  • Participants enrolled: 44
  • From 27 Oct 2021 to the primary completion date, 5 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\. Conditions: Co-morbidities that may influence pain perception; diagnosis of epilepsy or susceptibility to seizures, migraines, or other neurological disorders that may prevent VR use, and/or other medical conditions due to which individuals are predisposed to nausea and dizziness; susceptibility to claustrophobia, motion sickness or cybersickness (digital motion sickness); history of blackouts; hypersensitivity to flashing lights or motion; lack of stereoscopic vision; severe visual or hearing impairment; inability to operate VR equipment (such as inability to turn head or use hands to operate external controller); and/or injury to the eyes, face, head, or neck that prevents comfortable VR use.
    • 2\. Other exclusions: Medical instability as determined by healthcare providers at the study site; significant motor impairment; surgery within the last three months; planning to start a new pain management strategy (such as medication, physiotherapy, acupuncture, or cognitive behavioral therapy) in the next three months; history of major psychiatric disorder (such as schizophrenia or bipolar disorder) not controlled with medication or behavioral factors that would interfere with study procedures; alcohol or substance dependence, heart conditions, or the presence of implanted medical devices (such as cardiac pacemakers) as noted in the electronic health record; cognitive or developmental disabilities; active suicidal ideation; inability to read, write, or understand English; pregnancy; and/or plans for vacation in the next three months.
    • This study will not include any of these special populations:

Other

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Who the study is looking for

  • Black adults,
  • ages 18-50 years;
  • diagnosis of SCD (Sickle cell disease);
  • chronic non vaso-occlusive pain experienced \> 3 days per week on average for \> 6 months;
  • ability to wear a VR (Virtual reality) head-mounted display and move head in cervical rotation, extension, and flexion; sufficient fine motor control to operate VR equipment such as a controller; and ability to read, write, and understand English.

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Grady Memorial Hospital - Outpatient Sickle Cell Clinic
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.